ÂÜÀòÂÒÂ×

Christineh Sarkissian is currently an advisor at CaraVan Biologix. Christineh has previously worked at National PKU Alliance, National Institutes of Health, Rubius Therapeutics, Codexis, Inc., Enzolve Technologies Ltd., Tandem Biotherapeutics, The Canadian PKU Medical Working Group, and Canadian PKU and Allied Disorders Inc. Christineh has been in the medical field for over 20 years and has experience in preclinical development, consultancy, and patient advocacy.

Christineh Sarkissian has a Bachelor of Science in Genetics from York University, a Doctor of Philosophy in Biochemical Genetics - Drug Development from McGill University, and is certified in Drug and Medical Device Development: A Strategic Approach from MIT xPRO. Christineh is currently a Postdoctoral Fellow in Chemistry and Human Genetics at McGill University.